HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroid function and 3,3'-diiodothyronine sulfate cross-reactive substance (compound W) in maternal hyperthyroidism with antithyroid treatment.

AbstractOBJECTIVE:
To test whether the serial measurement of maternal levels of compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance, can serve as a potential indicator of fetal thyroid function in pregnant women receiving antithyroid medication.
METHODS:
Compound W was measured repeatedly in serum of pregnant women with hyperthyroidism treated with antithyroid medication. Free thyroxine levels of mothers and serum thyroid-stimulating hormone levels of 1-day-old neonates were analyzed by local clinical or state laboratories.
RESULTS:
Use of minimal antithyroid medication impaired the progressive increase of compound W seen in euthyroid mothers during pregnancy. At term, depressed compound W levels in maternal serum were found in 7 of 22 pregnancies; in 1 case, maternal compound W was suppressed and newborn thyroid-stimulating hormone was elevated. Seven mothers with treated hyperthyroidism failed to show an increase in serum levels of compound W after midterm.
CONCLUSION:
Normal progression of maternal serum compound W may be an index of normal fetal thyroid development in mothers with hyperthyroidism treated with necessary antithyroid medication.
AuthorsLester Vanmiddlesworth, N Rue Vanmiddlesworth, Robert S Egerman, Andrew J Bush, Risa D Ramsey, Lucinda P Delmar, Eugene C Ho, Sing-Yung Wu
JournalEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (Endocr Pract) 2011 Mar-Apr Vol. 17 Issue 2 Pg. 170-6 ISSN: 1934-2403 [Electronic] United States
PMID20713348 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antithyroid Agents
  • Diiodothyronines
  • compound W
  • Thyroxine
Topics
  • Adolescent
  • Adult
  • Antithyroid Agents (adverse effects, therapeutic use)
  • Diiodothyronines (blood)
  • Female
  • Humans
  • Hyperthyroidism (blood, drug therapy)
  • Infant, Newborn
  • Pregnancy
  • Thyroid Gland (embryology)
  • Thyroxine (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: